MRGPRX2 and allergic disease: Thus, the worsening cycle (MRGPRX2 → CTMC degranulation → chymase → DRG activation → SP → MRGPRX2) contributes to vascular hyperpermeability in MRGPRX2-KI mice in pseudo-allergy models, which is a novel point.